Correlation Between Inhibikase Therapeutics and Harvard Apparatus

Can any of the company-specific risk be diversified away by investing in both Inhibikase Therapeutics and Harvard Apparatus at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibikase Therapeutics and Harvard Apparatus into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Inhibikase Therapeutics and Harvard Apparatus Regenerative, you can compare the effects of market volatilities on Inhibikase Therapeutics and Harvard Apparatus and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibikase Therapeutics with a short position of Harvard Apparatus. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibikase Therapeutics and Harvard Apparatus.

Diversification Opportunities for Inhibikase Therapeutics and Harvard Apparatus

0.0

Correlation Coefficient

Inhibikase Therapeutics  Harvard Apparatus

Pay attention - limited upside

The 3 months correlation between Inhibikase and Harvard is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Inhibikase Therapeutics and Harvard Apparatus Regenerative in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Harvard Apparatus and Inhibikase Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibikase Therapeutics are associated (or correlated) with Harvard Apparatus. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Harvard Apparatus has no effect on the direction of Inhibikase Therapeutics i.e., Inhibikase Therapeutics and Harvard Apparatus go up and down completely randomly.

Pair Corralation between Inhibikase Therapeutics and Harvard Apparatus

If you would invest  269.00  in Inhibikase Therapeutics on October 7, 2024 and sell it today you would earn a total of  63.00  from holding Inhibikase Therapeutics or generate 23.42% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	2.44%
Values	Daily Returns

Inhibikase Therapeutics  vs.  Harvard Apparatus Regenerative

Inhibikase Therapeutics

Risk-Adjusted Performance

19 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Inhibikase Therapeutics are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady forward-looking signals, Inhibikase Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Harvard Apparatus

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Harvard Apparatus Regenerative has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, Harvard Apparatus is not utilizing all of its potentials. The newest stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Inhibikase Therapeutics and Harvard Apparatus

The main advantage of trading using opposite Inhibikase Therapeutics and Harvard Apparatus positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibikase Therapeutics position performs unexpectedly, Harvard Apparatus can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Harvard Apparatus will offset losses from the drop in Harvard Apparatus' long position.

The idea behind Inhibikase Therapeutics and Harvard Apparatus Regenerative pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.